Bender Robert & Associates’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $788K | Sell |
3,224
-120
| -4% | -$28K | 0.19% | 27 |
|
|
2025
Q4 | $692K | Sell |
3,344
-188
| -5% | -$37.2K | 0.14% | 28 |
|
|
2025
Q3 | $655K | Sell |
3,532
-20
| -0.6% | -$3.43K | 0.14% | 30 |
|
|
2025
Q2 | $543K | Sell |
3,552
-146
| -4% | -$22.4K | 0.12% | 30 |
|
|
2025
Q1 | $613K | Sell |
3,698
-21
| -0.6% | -$3.29K | 0.15% | 29 |
|
|
2024
Q4 | $538K | Buy |
3,719
+180
| +5% | +$27.9K | 0.13% | 32 |
|
|
2024
Q3 | $573K | Buy |
+3,539
| New | +$564K | 0.12% | 32 |
|
|
2024
Q2 | – | Sell |
-4,189
| Closed | -$623K | – | 64 |
|
|
2024
Q1 | $663K | Sell |
4,189
-412
| -9% | -$65.6K | 0.16% | 33 |
|
|
2023
Q4 | $721K | Sell |
4,601
-100
| -2% | -$15.3K | 0.18% | 32 |
|
|
2023
Q3 | $732K | Sell |
4,701
-408
| -8% | -$67.3K | 0.21% | 30 |
|
|
2023
Q2 | $846K | Sell |
5,109
-422
| -8% | -$68.1K | 0.23% | 32 |
|
|
2023
Q1 | $857K | Buy |
5,531
+34
| +0.6% | +$5.49K | 0.27% | 34 |
|
|
2022
Q4 | $971K | Sell |
5,497
-10
| -0.2% | -$1.73K | 0.36% | 30 |
|
|
2022
Q3 | $900K | Buy |
5,507
+400
| +8% | +$67.7K | 0.35% | 31 |
|
|
2022
Q2 | $907K | Hold |
5,107
| – | – | 0.35% | 32 |
|
|
2022
Q1 | $905K | Buy |
5,107
+121
| +2% | +$20.6K | 0.26% | 35 |
|
|
2021
Q4 | $805K | Hold |
4,986
| – | – | 0.23% | 34 |
|
|
2021
Q3 | $805K | Sell |
4,986
-35
| -0.7% | -$5.97K | 0.23% | 36 |
|
|
2021
Q2 | $827K | Buy |
5,021
+35
| +0.7% | +$5.79K | 0.24% | 35 |
|
|
2021
Q1 | $819K | Hold |
4,986
| – | – | 0.26% | 34 |
|
|
2020
Q4 | $785K | Hold |
4,986
| – | – | 0.25% | 34 |
|
|
2020
Q3 | $742K | Hold |
4,986
| – | – | 0.27% | 33 |
|
|
2020
Q2 | $701K | Sell |
4,986
-30
| -0.6% | -$4.37K | 0.28% | 34 |
|
|
2020
Q1 | $658K | Sell |
5,016
-30
| -0.6% | -$4.26K | 0.35% | 31 |
|
|
2019
Q4 | $736K | Hold |
5,046
| – | – | 0.33% | 32 |
|
|
2019
Q3 | $653K | Hold |
5,046
| – | – | 0.33% | 32 |
|
|
2019
Q2 | $660K | Buy |
5,046
+65
| +1% | +$9K | 0.31% | 32 |
|
|
2019
Q1 | $696K | Buy |
4,981
+146
| +3% | +$19.6K | 0.34% | 33 |
|
|
2018
Q4 | $624K | Sell |
4,835
-25
| -0.5% | -$3.49K | 0.36% | 33 |
|
|
2018
Q3 | $672K | Sell |
4,860
-5
| -0.1% | -$664 | 0.31% | 33 |
|
|
2018
Q2 | $590K | Buy |
4,865
+60
| +1% | +$7.49K | 0.31% | 33 |
|
|
2018
Q1 | $616K | Sell |
4,805
-575
| -11% | -$77.7K | 0.34% | 33 |
|
|
2017
Q4 | $752K | Sell |
5,380
-169
| -3% | -$23.5K | 0.42% | 28 |
|
|
2017
Q3 | $721K | Sell |
5,549
-20
| -0.4% | -$2.65K | 0.41% | 29 |
|
|
2017
Q2 | $737K | Sell |
5,569
-170
| -3% | -$21.7K | 0.45% | 27 |
|
|
2017
Q1 | $715K | Sell |
5,739
-175
| -3% | -$20.9K | 0.46% | 27 |
|
|
2016
Q4 | $681K | Sell |
5,914
-163
| -3% | -$18.8K | 0.48% | 28 |
|
|
2016
Q3 | $718K | Buy |
6,077
+165
| +3% | +$20K | 0.47% | 27 |
|
|
2016
Q2 | $717K | Buy |
5,912
+45
| +0.8% | +$5.11K | 0.51% | 29 |
|
|
2016
Q1 | $635K | Sell |
5,867
-350
| -6% | -$36.2K | 0.43% | 31 |
|
|
2015
Q4 | $639K | Buy |
6,217
+195
| +3% | +$19.6K | 0.41% | 32 |
|
|
2015
Q3 | $562K | Buy |
6,022
+635
| +12% | +$61.4K | 0.38% | 30 |
|
|
2015
Q2 | $525K | Sell |
5,387
-45
| -0.8% | -$4.51K | 0.31% | 31 |
|
|
2015
Q1 | $546K | Buy |
5,432
+235
| +5% | +$23.9K | 0.32% | 34 |
|
|
2014
Q4 | $543K | Buy |
5,197
+238
| +5% | +$25.1K | 0.36% | 33 |
|
|
2014
Q3 | $529K | Sell |
4,959
-86
| -2% | -$8.92K | 0.37% | 32 |
|
|
2014
Q2 | $528K | Sell |
5,045
-150
| -3% | -$15.2K | 0.37% | 32 |
|
|
2014
Q1 | $510 | Buy |
5,195
+40
| +0.8% | +$3.71K | 0.34% | 34 |
|
|
2013
Q4 | $472K | Buy |
5,155
+30
| +0.6% | +$2.77K | 0.35% | 36 |
|
|
2013
Q3 | $444K | Buy |
5,125
+195
| +4% | +$17.5K | 0.35% | 35 |
|
|
2013
Q2 | $423K | Buy |
+4,930
| New | +$418K | 0.36% | 35 |
|
Other funds holding JNJ
VCM
VPM
Bender Robert & Associates's JNJ Position: Q1 2026 in Review
Bender Robert & Associates reduced its Johnson & Johnson (JNJ) stake by 3.6% in Q1 2026, selling an estimated $28K and leaving 3,224 shares worth $788K. The position accounts for 0.19% of the portfolio, ranked #27.
Bender Robert & Associates first reported a position in JNJ in Q2 2013 and has held it in 51 quarters since. The position peaked at $971K in Q4 2022. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Bender Robert & Associates held 3,224 shares of Johnson & Johnson worth $788K as of Q1 2026.
- Bender Robert & Associates sold 120 Johnson & Johnson shares in Q1 2026, an estimated $28K.
- Johnson & Johnson made up 0.19% of Bender Robert & Associates's portfolio in Q1 2026, its #27 holding.
- Bender Robert & Associates first reported a position in Johnson & Johnson in Q2 2013 and has held it in 51 quarters since.
- Bender Robert & Associates's Johnson & Johnson position peaked at $971K in Q4 2022.
- 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Bender Robert & Associates's 13F filing for Q1 2026, filed 23 Apr 2026.